ClinConnect ClinConnect Logo
Search / Trial NCT06231394

Effectiveness of Multimodal Pelvic Floor Rehabilitation Program in Children With Different Types of Urinary Incontinence

Launched by DAMLA KORKMAZ DAYICAN · Jan 27, 2024

Trial Information

Current as of June 26, 2025

Recruiting

Keywords

Urinary Incontinence Nocturnal Enuresis Daytime Incontinence Pediatric Pelvic Floor Rehabilitation

ClinConnect Summary

This clinical trial is studying the effectiveness of a special rehabilitation program designed for children aged 5 to 18 who experience urinary incontinence, which is when they unintentionally leak urine. The program includes various components such as education, lifestyle changes, breathing exercises, muscle training, and a home practice plan. Researchers want to see how well this multimodal approach helps children with different types of urinary incontinence, including those who wet the bed at night, those who have daytime accidents, and those who experience both.

To participate, children must be between 5 and 18 years old and diagnosed with urinary incontinence by a pediatric urologist. They should also be able to read and write in Turkish and have a parent or guardian who can provide consent. Throughout the 10-week program, children will attend sessions twice a week, where their urinary symptoms and muscle functions will be assessed using various questionnaires and tests. This trial aims to help understand which aspects of the program work best for different types of urinary issues in children.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Being between the ages of 5-18
  • Having been diagnosed with urinary incontinence according to the International Children's Continence Society criteria by a pediatric urologist (daytime incontinence, nocturnal enuresis, combined daytime incontinence and nocturnal enuresis)
  • Signed the informed consent form
  • Parent or child's ability to read and write Turkish
  • Exclusion Criteria:
  • Presence of neurogenic lower urinary tract dysfunction
  • Presence of anatomical changes and malformations in the urinary system
  • Presence of active urinary system infection
  • Having previously undergone surgery to treat urinary incontinence
  • The child has any condition that would prevent participation in assessment or treatment (cognitive impairment, mental retardation, orthopedic disease or surgery, etc.)
  • Presence of congenital thorax deformity
  • The child has received pelvic floor rehabilitation within the last six months

About Damla Korkmaz Dayican

Damla Korkmaz Dayican is a dedicated clinical trial sponsor committed to advancing medical research and improving patient outcomes through innovative study designs and rigorous scientific methodologies. With a focus on collaboration and transparency, she leads initiatives that prioritize participant safety and ethical standards while fostering strong relationships with investigative sites and regulatory bodies. Leveraging her expertise in clinical operations, Damla aims to facilitate the efficient conduct of trials across various therapeutic areas, ultimately contributing to the development of groundbreaking treatments and therapies.

Locations

İzmir, Bornova, Turkey

Patients applied

0 patients applied

Trial Officials

Arzu Razak Özdinçler

Study Director

Fenerbahçe University

Damla Korkmaz Dayıcan

Principal Investigator

İzmir Tınaztepe University

Özge Çeliker Tosun

Principal Investigator

Dokuz Eylul University

Büşra Palaz

Principal Investigator

Dokuz Eylul University

İbrahim Ulman

Principal Investigator

Ege University

Ali Tekin

Principal Investigator

Ege University

Sibel Tiryaki

Principal Investigator

Ege University

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported